 |
|
|
SPDR S&P Biotech ETF
| Fund Name: |
SPDR S&P Biotech ETF |
| Issuer: |
State Street |
| Total Net Assets: |
$6,213,527,692 |
| Inception: |
01/31/2006 |
| Related Index: |
s&p biotechnology select industry index |
| ETF Category: |
Health |
| Expense Ratio: |
0.35% |
 |
| Net Asset Value: |
$83.24 |
| Recent NAV Premium: |
0.00% |
| NAV Symbol: |
XBI.NV |
| Number of Holdings: |
150 |
| Annualized Yield: |
0.00% |
| Annualized Distribution: |
0.000 |
|
| Stock |
Weight |
Amount |
| Immunogen |
2.53% |
$156,910,511 |
| TG Therapeutics |
1.74% |
$107,989,519 |
| Iveric Bio |
1.60% |
$99,165,469 |
| Prometheus Biosciences |
1.59% |
$98,595,167 |
| Viking Therapeutics |
1.52% |
$94,185,817 |
| List of all 149 stocks held by XBI
» |
|
|
|
|
|
Buy (3.37 out of 4)
85th percentile
|
| ETF |
Assets |
| SPY |
$392,036,312,343 |
| GLD |
$59,296,333,905 |
| XLK |
$47,347,081,868 |
| XLV |
$39,012,943,743 |
| XLE |
$34,238,918,842 |
| List of all 141 others
» |
|
| Shares Short |
38,380,000 |
| Chg. from Last Month |
-1,870,000 |
| Shares Outstanding |
79,620,000 |
| % of Shares Short |
48.20% |
| Days to Cover |
4.4 |
Based on third party short interest data.
|
|
|
|
Free XBI Email Alerts:
